Pilot Study of Bumetanide for Newborn Seizures: A Phase I Study of Pharmacokinetics and Safety of Bumetanide for Neonatal Seizures
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 17 Oct 2017
At a glance
- Drugs Bumetanide (Primary) ; Phenobarbital
- Indications Neonatal seizures
- Focus Adverse reactions; Pharmacokinetics
- 10 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Aug 2018.
- 10 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Aug 2018.
- 11 Apr 2017 Status changed from recruiting to active, no longer recruiting.